Bruker Corporation has announced the creation of a new division, Bruker Spatial Biology, aimed at advancing research in spatial biology, a field that focuses on understanding how molecules are organized within cells and tissues. The new division brings together key technologies from NanoString Technologies, Canopy Biosciences, and Bruker’s own subsidiary, Bruker Spatial Genomics, Inc.
Bruker Spatial Biology will offer a range of tools designed for different areas of research, including spatial genomics, transcriptomics, and proteomics. These platforms, such as NanoString’s GeoMx®, CosMx™, and AtoMx™, along with Canopy Biosciences’ CellScape™, provide researchers with options for studying how genes and proteins are spatially arranged in cells—an important aspect of understanding disease and developing new treatments.
According to Mark R. Munch, PhD, President of Bruker’s NANO group, the goal is to provide researchers with the most advanced tools available to study biological systems in more detail. “With these platforms, researchers can visualize the 3D structure of the genome, study gene expression at both regional and single-cell levels, and perform precise protein analysis,” he said.
Todd Garland, President of the new Bruker Spatial Biology division, emphasized that this integration allows for more customized research solutions. “We’re bringing together a diverse range of platforms so we can offer tailored solutions that fit the unique needs of each research project,” Garland explained.
Bruker Spatial Biology will be showcasing its technologies at the upcoming Society for Immunotherapy of Cancer (SITC) 2024 conference in Houston, Texas, from November 8-10.